Skip to search formSkip to main contentSkip to account menu

Proellex

National Institutes of Health

Related topics

Related topics

2 relations
Progenta

Broader (1)

telapristone acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A Six-Month Baboon Study Comparing Two Anti-Hormones Given Separately and Simultaneously
Background: Telapristone (CDB-4124 or Proellex®) is a PRM (progesterone antagonist) under development for treatment of uterine… 
2017
2017
Abstract OT3-02-09: Phase II pre-surgical window trial of telapristone acetate (TPA) in early breast cancer and DCIS patients: Distribution of TPA in plasma, normal breast tissue and tumors
Background:In vitro and preclinical data support the notion that anti-progesterone therapy will have activity against both… 
2013
2013
Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells
2011
2011
The state-of-the-art of emergency contraception with the cutting edge drug
  • N. Sarkar
  • German medical science : GMS e-journal
  • 2011
  • Corpus ID: 13557711
The objective of this study is to evaluate and elucidated the potential of selective progesterone receptor modulators (SPRMs) to… 
2010
2010
Abstract P4-02-07: A Progesterone Receptor Modulator, CDB-4124, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation In Vitro and In Vivo
CDB-4124 (Proellex or Telapristone acetate) is a modulator of progesterone receptor (PR) signaling which has been employed in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)